CML
Conference Coverage
Pediatric cancer survivors at risk for opioid misuse
From the Journals
Poor survival with COVID in patients who have had HSCT
Conference Coverage
Omidubicel improves on umbilical cord blood transplants
From the Journals
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...
Conference Coverage
On the horizon: Asciminib, a new drug for treating r/r CML
“Although we have many excellent therapies for CML, having a new medication that targets BCR-ABL in a novel way is still welcome to help us better...
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
Conference Coverage
New data and trial outcomes clarify path to TFR in CML
“I think it’s an important message that the [cardiovascular event] risk is there, at about the same rate, in the second 5 years.”
Conference Coverage
CML: New TKIs and combos show promise for resistant, intolerant disease
Conference Coverage
Baseline gene expression predicts TKI response in CML
Conference Coverage
Inotuzumab / bosutinib treat R/R Ph+ ALL, CML in blast phase
Conference Coverage
Complementary medicine use common among patients on TKIs
GLASGOW – A survey of chronic myeloid leukemia patients taking tyrosine kinase inhibitors (TKIs) revealed that more than one-third were taking...